FGFR3 antibodies and methods of use
US11505611B2 · kind B2 · utility
0Cited by
36References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 20, 2021 |
| Grant date | Nov 22, 2022 |
| Priority date | — |
| Expiry date | Aug 20, 2041 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Anti-FGFR3 antigen-binding proteins and antigen-binding binding fragments thereof are provided. Methods of inhibiting FGFR3 activity and methods of treating FGFR3-mediated diseases and disorders are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.